The President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products is a central government administrative authority competent for matters concerning:
1. marketing authorization of medicinal products, excluding medicinal products which do not need marketing authorization - within the scope determined by the Act of the 6th of September 2011 on Pharmaceutical Law (O.J. 2008, No 45, item 271, as amended);
2. marketing authorization of biocidal products - within the scope determined by the Act of the 9th of October on biocidal products (O.J. of 2015, item 1926);
3. marketing and use of medical devices - within the meaning and on the basis of the Act on Medical Devices of the 20th of May 2010 (O.J. No 107, item 679, as amended);
4. clinical trials, including veterinary clinical trials - within the scope determined by the Act of the 6th of September 2001 on Pharmaceutical Law and Medical Devices Act of 20 May 2010.